CytRx Corp (CYTR)

OTC Markets
0.100
+0.007(+7.53%)
  • Volume:
    2,425
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    0.090 - 0.100

CYTR Overview

Prev. Close
0.093
Day's Range
0.09-0.1
Revenue
-
Open
0.09
52 wk Range
0.052-0.999
EPS
-0.35
Volume
2,425
Market Cap
4.5M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
195,673
P/E Ratio
-
Beta
2.14
1-Year Change
-89.99%
Shares Outstanding
45,037,391
Next Earnings Date
Aug 10, 2022
What is your sentiment on CytRx?
or
Market is currently closed. Voting is open during market hours.

CytRx Corp News

CytRx Corp Analysis

CytRx Corp Company Profile

CytRx Corp Company Profile

Employees
4

CytRx Corporation is a biopharmaceutical research and development company specializing in oncology and rare diseases. The Company is focused on the discovery, research and clinical development of anti-cancer drug candidates that employ linker technologies to enhance the accumulation and release of cytotoxic anti-cancer agents at the tumor. The Company's Linker Activated Drug Release (LADR) technology platform is a discovery engine to create a pipeline of anti-cancer molecules that avoid unacceptable systemic toxicity while delivering highly potent agents directly to the tumor. Its product candidate, Aldoxorubicin is a rationally engineered cytotoxic which delivers anti-cancer agent, doxorubicin, into the tumor is in late-stage clinical trials. Its other product candidate, Arimoclomol for Niemann Pick disease Type C (NPC) and Gaucher disease.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyNeutralNeutralSellStrong Sell
Technical IndicatorsStrong BuyBuyStrong BuyStrong SellStrong Sell
SummaryStrong BuyNeutralBuyStrong SellStrong Sell
  • I am buying at these levels
    0
    • anyone buying?
      0
      • no one following this
        0
        • on the way to 10
          0
          • ooops....
            0
            • ASCO presentation begins today. Should be great news for CYTR
              0
              • Would be nice to see something in the media about cytr in the event. Stock is stagnating with all the silence.
                0
            • Purchase 15000 shares at an average price $0.50 my 6 month projection is $1 a share
              0
              • Can it be up till $10 in 3 or 4 years?
                0
              • I don't think you need to wait that long.
                0